Expanding the Role of the Microscopic Observation Drug Susceptibility Assay in Tuberculosis and HIV Management

Clinical Infectious Diseases

Volumn 50, Issue 7, 2010, Pages 997-999

  Minion, Jessica ^a,b   Pai, Madhukar ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN;

BACTERIAL GROWTH; BACTERIUM CULTURE; DISEASE TRANSMISSION; DRUG SENSITIVITY; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; MORBIDITY; MORTALITY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NOTE; PRIORITY JOURNAL; SPUTUM SMEAR; TUBERCULOSIS; TUBERCULOSIS CONTROL; WORLD HEALTH ORGANIZATION;

ANTITUBERCULAR AGENTS; BACTERIAL TYPING TECHNIQUES; HIV INFECTIONS; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MICROSCOPY; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 77749331012     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/651082     Document Type: Note

References (25)

1. Pai M, Minion J, Sohn H, Zwerling A, Perkins MD. Novel and improved technologies for tuberculosis diagnosis: progress and challenges. Clin Chest Med 2009;30:701-716, viii.
2. Pai M, Ramsay A, O'Brien R. Evidence-based tuberculosis diagnosis. PLoS Med 200822;5: el.56.
3. 3. Getahun H, Harrington M, O'Brien R, Nunn P. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet 2007; 369:2042-2049. (Pubitemid 46908825)
4. Ait-Khaled N, Alarcon E, Bissell K, et al. Isoniazid preventive therapy for people livingwith HIV: public health challenges and implementation issues. Int J Tuberc Lung Dis 2009; 13:927-935.
5. Landry J, Menzies D. Preventive chemotherapy: where has it got us? where to go next? Int J Tuberc Lung Dis 2008; 12:1352-1364.
6. 6. Cruciani M, Scarparo C, Malena M., Bosco O, Serpelloni G, Mengoli C. Meta-analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without solid media, for detection of mycobacteria. J Clin Microbiol 2004; 42: 2321-2325. (Pubitemid 38637876)
7. Reddy KP, Brady MF, Gilman RH, et al. Microscopic observation drug susceptibility assay for tuberculosis screening before isoniazid preventive therapy in HIV-infected persons. Clin Infect Dis 2010;50:997-999 (in this is- sue).
8. Caviedes L, Lee TS, Gilman RH, et al; The Tuberculosis Working Group in Peru. Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. J Clin Microbiol 2000; 38:1203-1208.
9. World Health Organization HIV/AIDS and TB Department. WHO Three I's meeting: intensified case finding (ICF), isoniazid preventive therapy (IPT) and TB infection control (IC) for people living with HIV: report of a Joint World Health Organization HIV/AIDS and TB Department Meeting. Geneva, Switzerland: World Health Organization, 2-4 April 2008. http://www.who.int/tb/publications/ 2009/who-3Is-meeting-report.pdf Accessed 9 December 2009.
10. Ridderhof JC, van Deun A, Kam KM, Narayanan PR, Aziz MA. Roles of laboratories and laboratory systems in effective tuberculosis programmes. Bull World Health Organ 2007;85:354-359.
11. World Health Organization. The use of liquid medium for culture and DST. Geneva, Switzerland: World Health Organization, 2007. http://www.who.int/tb/ dots/laboratory/policy/en/index3.html. Accessed 9 December 2009.
12. World Health Organization (WHO). Policy statement: molecular line probe assays for rapid screening of patients at risk of multidrug resistant tuberculosis (MDR-TB). Geneva, Switzerland: World Health Organization, 27 June 2008. http://www.who.int/tb/features-archive/policy-statement.pdf. Accessed 9 December 2009.
13. World Health Organization. Global tuberculosis control 2009: epidemiology, strategy, financing. Geneva, Switzerland: World Health Organization, 2009. http://www.who.int/tb/publications/global-report/2009/pdf/ full-report.pdf Accessed 9 December 2009.
14. Arias M, Mello FC, Pavon A, Marsico AG, et al. Clinical evaluation of the microscopic-observation drug-susceptibility assay for detection of tuberculosis. Clin Infect Dis 2007; 44: 674-680. (Pubitemid 46272976)
15. 15. Caws M, Dang TM, Torok E, et al. Evaluation of the MODS culture technique for the diagnosis of tuberculous meningitis. PLoS ONE 2007; 2:e1173. (Pubitemid 351638016)
16. Irfan S, Hasan R, Kanji A, Hassan Q, Azam I. Evaluation of a microcolony detection method and phage assay for rapid detection of Mycobacterium tuberculosis in sputum samples. Southeast Asian J Trop Med Public Health 2006;37:1187-1195.
17. Michael J, Daley P, Kalaiselvan S, et al. Diagnostic accuracy of microscopic observation drug susceptibility assay (MODS): a pilot study from India. Int J Tuberc Lung Dis (in press).
18. 18. Moore DAJ, Mendoza D, Gilman RH, et al. Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J Clin Microbiol 2004; 42:4432-4437. (Pubitemid 39362351)
19. Moore DA, Evans CA, Gilman RH, et al. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 2006;355:1539-1550.
20. Oberhelman RA, Soto-Castellares G, Caviedes L, et al. Improved recovery of Mycobacterium tubercubsis from children using the microscopic observation drug susceptibility method. Pediatrics 2006; 118:e100-e106.
21. Shiferaw G, Woldeamanuel Y, Gebeyehu M, Girmachew F, Demessie D, Lemma E. Evaluation of microscopic observation drug susceptibility assay for detection of multidrugresistant Mycobacterium tuberculosis. J Clin Microbiol 2007;45:1093-1097.
22. Tovar M, Siedner MJ, Gilman RH, et al. Improved diagnosis of pleural tuberculosis using the microscopic- observation drug-susceptibility technique. Clin Infect Dis 2008; 46:909-912.
23. Brady MF, Coronel J, Gilman RH, Moore DA. The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis. J Vis Exp 2008; 17:845.
24. Dowdy DW, O'Brien MA, Bishai D. Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis. Int J Tuberc Lung Dis 2008; 12:1021-1029.
25. Dowdy DW, Chaisson RE, Maartens G, Corbett EL, Dorman SE. Impact of enhanced tuberculosis diagnosis in South Africa: a mathematical model of expanded culture and drug susceptibility testing. Proc Natl Acad Sci U S A 2008; 105:11293-11298.